Does NATALIZUMAB-SZTN Cause Progressive multifocal leukoencephalopathy? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Progressive multifocal leukoencephalopathy have been filed in association with NATALIZUMAB-SZTN. This represents 3.7% of all adverse event reports for NATALIZUMAB-SZTN.
7
Reports of Progressive multifocal leukoencephalopathy with NATALIZUMAB-SZTN
3.7%
of all NATALIZUMAB-SZTN reports
2
Deaths
5
Hospitalizations
How Dangerous Is Progressive multifocal leukoencephalopathy From NATALIZUMAB-SZTN?
Of the 7 reports, 2 (28.6%) resulted in death, 5 (71.4%) required hospitalization.
Is Progressive multifocal leukoencephalopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NATALIZUMAB-SZTN. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does NATALIZUMAB-SZTN Cause?
Fatigue (63)
Mobility decreased (52)
Balance disorder (31)
Headache (18)
Product substitution issue (17)
Multiple sclerosis relapse (16)
Muscular weakness (16)
Cognitive disorder (13)
Gait disturbance (13)
Dizziness (11)
What Other Drugs Cause Progressive multifocal leukoencephalopathy?
NATALIZUMAB (1,668)
RITUXIMAB (1,647)
CYCLOPHOSPHAMIDE (782)
PREDNISONE (606)
PREDNISOLONE (439)
TACROLIMUS (438)
METHOTREXATE (428)
DOXORUBICIN (421)
MYCOPHENOLATE MOFETIL (414)
VINCRISTINE (376)
Which NATALIZUMAB-SZTN Alternatives Have Lower Progressive multifocal leukoencephalopathy Risk?
NATALIZUMAB-SZTN vs NATAMYCIN
NATALIZUMAB-SZTN vs NATEGLINIDE
NATALIZUMAB-SZTN vs NAVITOCLAX
NATALIZUMAB-SZTN vs NAXITAMAB-GQGK
NATALIZUMAB-SZTN vs NEBIVOLOL